UCP1 and obesity due to melanocortin 4 receptor deficiency: Recent studies have confirmed that WAT browning manifested as UCP1 up-regulation can battle against obesity and hyperlipidemia, making it a promising target for obesity treatment (Chen et al., 2023; Pacifici et al., 2023).